COMP <GO>
GNTX vs DORM // EV/EBITDA & P/E VALUATION
Gentex Corporation (NASDAQ) VS. Dorman Products Inc. (NASDAQ) • 15-METRIC TALLY: GNTX 9
— DORM 3
▲ EV/EBITDA & P/E VALUATION LEADER: GNTX
LAST: $20.26 (+0.95%) • MKT CAP: $4.27B
valuation
7.5x
LAST: $133.67 (+3.03%) • MKT CAP: $3.94B
valuation
12.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GNTX VS. DORM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GNTX | DORM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.20% | 42.10% | -7.90 | DORM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.80% | 12.90% | +1.90 | GNTX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.5x | 12.9x | -5.40 | GNTX | /valuation <GO> |
| Free Cash Flow Yield | 11.08% | 1.92% | +9.16 | GNTX | /fcf-yield <GO> |
| Operating Margin | 18.70% | 14.10% | +4.60 | GNTX | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 9.60% | +5.60 | GNTX | /net-margins <GO> |
| Revenue Growth (YoY) | 9.60% | 6.00% | +3.60 | GNTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.50% | 0.00% | +2.50 | GNTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.26 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | DORM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.7 | 69.3 | -29.63 | DORM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | 17.9x | -7.60 | GNTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.27B | $3.94B | $326.0M | GNTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GNTX REV | DORM REV | GNTX GROSS % | DORM GROSS % | GNTX FCF | DORM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $2.13B | 34.2% | 42.1% | $473.1M | $75.7M |
| FY 2024 | $2.31B | $2.01B | 33.3% | 40.1% | $394.1M | $191.6M |
| FY 2023 | $2.30B | $1.93B | — | — | $433.8M | $208.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GNTX // BETA 0.97
DORM // BETA —